Nucleus Biologics Announces Supplier Agreement with IMPAACT Network

August 10, 2018 News Tags:

Nucleus Biologics encourages researchers to pursue excellence in their experimental reproducibility. We are pleased to announce that the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network has selected us as an approved supplier for their fetal bovine serum (FBS) needs. Laboratories working with IMPAACT are now able to use our FBS for all cell culture experiments and PBMC cryopreservation, ensuring reagent standardization network-wide.

About IMPAACT: The IMPAACT Network is a global collaboration of investigators, institutions, community representatives and other partners organized for the purpose of evaluating interventions to treat and prevent HIV infection and its consequences in infants, children, adolescents and pregnant/postpartum women through the conduct of high quality clinical trials.

Get exclusive updates direct to your inbox.

Subscribe